The University of Chicago Header Logo

Connection

Richard Schilsky to Angiogenesis Inhibitors

Back to Details
This is a "connection" page, showing publications Richard Schilsky has written about Angiogenesis Inhibitors.
Richard Schilsky
Connection Strength
0.125
Angiogenesis Inhibitors
  1. Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial. JAMA. 2017 06 20; 317(23):2392-2401.
    View in: PubMed
    Score: 0.125
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.